Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury
Frontiers in Pharmacology · 23.07.2024 · 15
DOI: 10.3389/fphar.2024.1406454 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 23.07.2024. Verfasst von Quanxian Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tuberculosis, Affiliated Hospital of Zunyi Medical University, Zunyi, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To analyze the clinical and laboratory characteristics and to identify predictors of moderate to severe anti-tuberculosis drug-induced liver injury (ATB-DILI) in patients with tuberculosis.
Methods
This prospective study enrolled Tuberculosis (TB) patients treated with first-line anti-tuberculosis drugs at the Affiliated Hospital of Zunyi Medical University between May 2022 and June 2023. The occurrence of ATB-DILI was monitored, and demographic and clinical data were gathered. We analyzed risk factors for the development of moderate to severe ATB-DILI.
Results
ATB-DILI was detected in 120 (10.7%) of the patients, with moderate to severe ATB-DILI occurring in 23 (2.0%) of the 1,124 patients treated with anti-tuberculosis treatment. Multivariate cox regression analysis identified malnutrition (HR = 4.564, 95% CI: 1.029–20.251, p = 0.046) and hemoglobin levels <120 g/L (HR = 2.825, 95% CI: 1.268–11.540, p = 0.017) as independent risk factors for moderate to severe ATB-DILI.
Conclusion
The incidence of moderate to severe ATB-DILI was found to be 2.0%. Malnutrition and hemoglobin levels below 120 g/L emerged as significant independent risk factors for the occurrence of moderate to severe ATB-DILI in this patient population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Tuberculosis, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Zitieren
APA
Liu, Q., Huang, L., Yan, H., Zong, Z., Chen, Z., Wu, X., Chen, L., & Lan, Y. (2024). Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1406454
Vancouver
Liu Q, Huang L, Yan H, Zong Z, Chen Z, Wu X, et al. Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1406454
BibTeX
@article{Liu2024,
author = {Liu, Quanxian and Huang, Lu and Yan, Hong and Zong, Zhaojing and Chen, Zhenyong and Wu, Xiaoyan and Chen, Ling and Lan, Yuanbo},
title = {Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1406454}
}
EUVIMED